{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:32:03Z","timestamp":1773419523946,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1624,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1540-8183.2011.00632.x","type":"journal-article","created":{"date-parts":[[2011,3,23]],"date-time":"2011-03-23T03:49:22Z","timestamp":1300852162000},"page":"351-356","source":"Crossref","is-referenced-by-count":13,"title":["Integrilin in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction"],"prefix":"10.1111","volume":"24","author":[{"given":"MICHAEL","family":"MAHMOUDI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CEDRIC","family":"DELHAYE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KOHEI","family":"WAKABAYASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"REBECCA","family":"TORGUSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHENYI","family":"XUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WILLIAM O.","family":"SUDDATH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LOWELL F.","family":"SATLER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KENNETH M.","family":"KENT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AUGUSTO D.","family":"PICHARD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RON","family":"WAKSMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,3,22]]},"reference":[{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Schomig","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1161\/01.CIR.99.15.1972","article-title":"Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: Importance of microvascular reperfusion injury on clinical outcome","volume":"99","author":"Claeys","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0002-9149(98)00508-6","article-title":"Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty","volume":"82","author":"Santoro","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.93.2.223","article-title":"Clinical implications of the \u2018no reflow\u2019 phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction","volume":"93","author":"Ito","year":"1996","journal-title":"Circulation"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","article-title":"Platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction","volume":"344","author":"Montalescot","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","article-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","volume":"346","author":"Stone","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0195-668X(02)00324-1","article-title":"Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty","volume":"24","author":"Petronio","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1093\/eurheartj\/ehi293","article-title":"Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: Results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial","volume":"26","author":"Zeymer","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0735-1097(99)00635-X","article-title":"Effect of glycoprotein IIb\/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction","volume":"35","author":"Neumann","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jacc.2003.07.017","article-title":"A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction","volume":"42","author":"Antoniucci","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/jama.293.14.1759","article-title":"Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: A meta-analysis of randomized trials","volume":"293","author":"De Luca","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000095343","article-title":"Clinical outcomes comparing eptifibatide and abciximab in ST elevation acute myocardial infarction patients undergoing percutaneous coronary interventions","volume":"107","author":"Midei","year":"2007","journal-title":"Cardiology"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4065\/82.2.196","article-title":"Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction","volume":"82","author":"Raveendran","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCINTERVENTIONS.108.847582","article-title":"Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: A safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST)","volume":"2","author":"Le May","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/00005344-200304000-00011","article-title":"Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates","volume":"41","author":"Moser","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jacc.2004.02.059","article-title":"Ability of anti-glycoprotein IIb\/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions","volume":"44","author":"Goto","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty","volume":"330","author":"Epic","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB19|cit19","first-page":"668","article-title":"Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Results of the Time to Integrilin Therapy in Acute Myocardial Infarction [TITAN]-TIMI 34 trial","volume":"152","author":"Gibson","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ccd.21059","article-title":"Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb\/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trial","volume":"70","author":"Dery","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.0000137912.11655.F6","article-title":"Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: An INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy","volume":"110","author":"Gibson","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1540-8183.2011.00632.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Journal of Interventional Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8183.2011.00632.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1540-8183.2011.00632.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T13:02:55Z","timestamp":1612702975000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1540-8183.2011.00632.x"}},"subtitle":["INTEGRILIN IN PATIENTS UNDERGOING PRIMARY PCI"],"short-title":[],"issued":{"date-parts":[[2011,3,22]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1540-8183.2011.00632.x","relation":{},"ISSN":["0896-4327"],"issn-type":[{"value":"0896-4327","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,22]]}}}